To access this element change to forms mode OFF
Grant Award View - GA40805
Aldosterone bloCkade for Health Improvement EValuation in End-stage...
GA ID:
GA40805
Agency:
Department of Health and Aged Care
Approval Date:
29-Mar-2019
Publish Date:
26-Apr-2019
Category:
Medical Research
Grant Term:
1-Apr-2019 to 31-Mar-2024
Value (AUD):
$2,850,898.40
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DoHAC 18/19 1.1 Health and Medical Research
Grant Program:
2018_MRFF Rare Cancers Rare Diseases, Unmet Need_commencing_2018
Grant Activity:
Aldosterone bloCkade for Health Improvement EValuation in End-stage renal disease (ACHIEVE) study
Purpose:
The ACHIEVE Study aims to improve the poor outcomes of patients with kidney failure, which are mostly driven by heart disease. It will study an existing drug, spironolactone, that is proven to benefit patients with heart failure. Spironolactone is rarely used in kidney failure as few studies have tested it, and there are concerns about its side effects in this patient group. This large, international study will provide reliable evidence as to whether this promising treatment works.
GO ID:
GO Title:
Medical Research Future Fund Clinical Trials Activity – Rare Cancers, Rare Diseases and Unmet Need Grant Opportunity
Internal Reference ID:
MRF1170347
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of New South Wales
Recipient ABN:
57 195 873 179
Grant Recipient Location
Suburb:
Sydney
Town/City:
Sydney
Postcode:
2052
State/Territory:
NSW
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW
Postcode:
Country:
AUSTRALIA